05:55 PM EDT, 03/17/2025 (MT Newswires) -- Christopher Richard Anzalone, Director, Chief Executive Officer, on March 13, 2025, sold 51,425 shares in Arrowhead Pharmaceuticals ( ARWR ) for $774,975. Following the Form 4 filing with the SEC, Anzalone has control over a total of 4,062,377 common shares of the company, with 4,062,377 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/879407/000162828025013210/xslF345X05/wk-form4_1742247926.xml